Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F11 | P03951 | 2/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.32 |
| ▸ | LPL | P06858 | 1/20 | 0.31 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.31 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25919603 | 0.73 | F11 (0.40) | F11F2PRSS1PRSS2PRSS3 | |
| SCHEMBL25199762 | 0.71 | NOS1 (0.38) | LPLLIPGUSP30 | |
| SCHEMBL25919482 | 0.70 | F11 (0.37) | F11F2PRSS1PRSS2PRSS3 | |
| SCHEMBL25919474 | 0.68 | F11 (0.38) | F11F2PRSS1PRSS2PRSS3 | |
| SCHEMBL25919471 | 0.68 | F11 (0.48) | F11F2PRSS1PRSS2PRSS3 | |
| SCHEMBL2033207 | 0.67 | NOS1 (0.40) | — | |
| SCHEMBL12580732 | 0.67 | NOS1 (0.40) | — | |
| SCHEMBL25318064 | 0.65 | F11 (0.55) | F11F2PRSS1PRSS2PRSS3 | |
| SCHEMBL25318058 | 0.65 | F11 (0.55) | F11F2PRSS1PRSS2PRSS3 | |
| SCHEMBL25919607 | 0.64 | F11 (0.40) | F11F2PRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023141114-A2 | SYNTHESIS OF BORON-CONTAINING AMIDOXIME REAGENTS AND THEIR APPLICATION TO SYNTHESIZE FUNCTIONALIZED OXADIAZOLE AND QUINAZOLINONE DERIVATIVES | LONG ISLAND UNIVERSITY (US) | 2023-07-27 | — | — | WO | disclosed |